EHI
AXSM icon

Eagle Health Investments’s Axsome Therapeutics AXSM Stock Holding History

Eagle Health Investments’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9M Buy
+65,051
New +$14.1M 2.64% 15

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Eagle Health Investments's AXSM Position: Q2 2026 in Review

Eagle Health Investments opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 65,051 shares worth $15.9M. The stake represents 2.64% of the portfolio and ranks #15 among its holdings.

202 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Eagle Health Investments held 65,051 shares of Axsome Therapeutics worth $15.9M as of Q2 2026.
  • Axsome Therapeutics was a new Eagle Health Investments position in Q2 2026.
  • Axsome Therapeutics made up 2.64% of Eagle Health Investments's portfolio in Q2 2026, its #15 holding.
  • 202 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.